HRP990394A2 - Aryl carboxylic acid and tetrazole derivatives - Google Patents

Aryl carboxylic acid and tetrazole derivatives Download PDF

Info

Publication number
HRP990394A2
HRP990394A2 HR990394A HRP990394A HRP990394A2 HR P990394 A2 HRP990394 A2 HR P990394A2 HR 990394 A HR990394 A HR 990394A HR P990394 A HRP990394 A HR P990394A HR P990394 A2 HRP990394 A2 HR P990394A2
Authority
HR
Croatia
Prior art keywords
compound according
acetic acid
compound
phenoxy
disease
Prior art date
Application number
HR990394A
Other languages
English (en)
Croatian (hr)
Inventor
Francisco Javier Lopez-Tapia
Alexander Victor Muehldorf
Counde O'yang
Daniel Lee Severance
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HRP990394A2 publication Critical patent/HRP990394A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
HR990394A 1998-12-23 1999-12-20 Aryl carboxylic acid and tetrazole derivatives HRP990394A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11344698P 1998-12-23 1998-12-23
US15181499P 1999-08-30 1999-08-30

Publications (1)

Publication Number Publication Date
HRP990394A2 true HRP990394A2 (en) 2000-08-31

Family

ID=26811078

Family Applications (1)

Application Number Title Priority Date Filing Date
HR990394A HRP990394A2 (en) 1998-12-23 1999-12-20 Aryl carboxylic acid and tetrazole derivatives

Country Status (29)

Country Link
US (1) US6335459B1 (fr)
EP (1) EP1013639B1 (fr)
JP (1) JP3415085B2 (fr)
KR (1) KR100378335B1 (fr)
CN (1) CN1167670C (fr)
AR (1) AR029320A1 (fr)
AT (1) ATE251125T1 (fr)
AU (1) AU735640B2 (fr)
BR (1) BR9905974A (fr)
CA (1) CA2292921C (fr)
DE (1) DE69911726T2 (fr)
DK (1) DK1013639T3 (fr)
ES (1) ES2207108T3 (fr)
HR (1) HRP990394A2 (fr)
HU (1) HUP9904659A3 (fr)
ID (1) ID25983A (fr)
IL (1) IL133578A (fr)
MA (1) MA26713A1 (fr)
NO (1) NO316171B1 (fr)
NZ (1) NZ501891A (fr)
PE (1) PE20001368A1 (fr)
PL (1) PL337419A1 (fr)
PT (1) PT1013639E (fr)
RU (1) RU2179969C2 (fr)
SG (1) SG90086A1 (fr)
TR (1) TR199903310A3 (fr)
TW (1) TWI221834B (fr)
UY (1) UY25876A1 (fr)
YU (1) YU69699A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828442D0 (en) 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
SE0100158D0 (sv) * 2001-01-19 2001-01-19 Synphora Ab Novel method and composition for local treatment of Meniere´s disease and tinnitus
CA2438813C (fr) * 2001-03-02 2008-07-29 F. Hoffmann-La Roche Ag Derives d'acide alcoxycarbonylaminoheteroaryle carboxylique en tant qu'antagonistes d'ip
ES2636943T3 (es) 2003-05-09 2017-10-10 Toray Industries, Inc. Beraprost y un inhibidor del sistema renina-angiotensina para usar en el tratamiento de enfermedades renales
RU2268037C1 (ru) * 2004-04-22 2006-01-20 Германов Евгений Павлович Лекарственное средство
UA93548C2 (uk) 2006-05-05 2011-02-25 Айерем Елелсі Сполуки та композиції як модулятори хеджхогівського сигнального шляху
US9669381B2 (en) 2007-06-27 2017-06-06 Hrd Corporation System and process for hydrocracking
KR20230085944A (ko) 2008-03-18 2023-06-14 아레나 파마슈티칼스, 인크. 프로스타시클린 （ｐｇｉ２） 수용체와 관련된 장애의 치료에 유용한 상기 수용체의 조절제
US8575175B2 (en) 2008-07-23 2013-11-05 Toray Industries, Inc. Therapeutic agent for chronic renal failure
AU2011263416B2 (en) 2010-06-11 2014-04-10 Rhodes Technologies Process for N-dealkylation of tertiary amines
CA2802295C (fr) 2010-06-11 2016-09-20 Rhodes Technologies Procedes catalyses par metal de transition pour la preparation de composes de n-allyle et utilisation de ceux-ci
EP3977985B1 (fr) 2017-03-01 2023-09-06 Arena Pharmaceuticals, Inc. Compositions comprenant des agonistes du récepteur pgi2 et procédés de préparation associés
US12098116B2 (en) 2022-02-15 2024-09-24 United Therapeutics Corporation Crystalline prostacyclin (IP) receptor agonist and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1079414A (en) 1965-06-30 1967-08-16 Smith & Nephew Derivatives of acetic acid and a process for their preparation
GB1185539A (en) 1967-11-03 1970-03-25 Smith & Nephew Substituted Tetrazoles
DE2432560A1 (de) 1974-07-06 1976-01-22 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeurederivate und verfahren zur herstellung derselben
JPS5832859A (ja) 1981-08-20 1983-02-25 Dainippon Pharmaceut Co Ltd Ｎ，ｎ−ジメチルカルバミン酸ベンジルエステル誘導体
JPH0725725B2 (ja) 1987-07-23 1995-03-22 保土谷化学工業株式会社 ベンズアミド誘導体
US5084466A (en) 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
CA2090283A1 (fr) 1992-02-28 1993-08-29 Nobuyuki Hamanaka Derives de l'acide phenoxyacetique
CA2183063A1 (fr) 1994-02-10 1995-08-17 Atsushi Ichikawa Recepteur de la prostaglandine i2
WO1995024393A1 (fr) 1994-03-10 1995-09-14 Fujisawa Pharmaceutical Co., Ltd. Derives de naphtalene utilises comme agonistes de la prostaglandine i2
US5753700A (en) 1994-12-28 1998-05-19 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives
TW401408B (en) 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism
JP3909864B2 (ja) 1995-07-26 2007-04-25 小野薬品工業株式会社 ナフチルオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤
DE19619445C1 (de) * 1996-05-14 1997-09-25 Bayer Ag Verfahren zur Herstellung von optisch aktiver N-Phenylcarbamat-milchsäure
AUPP029197A0 (en) 1997-11-10 1997-12-04 Fujisawa Pharmaceutical Co., Ltd. Benzocycloheptene derivatives
AUPP109097A0 (en) 1997-12-22 1998-01-22 Fujisawa Pharmaceutical Co., Ltd. Napthalene derivatives

Also Published As

Publication number Publication date
ES2207108T3 (es) 2004-05-16
YU69699A (sh) 2001-12-26
NZ501891A (en) 2001-10-26
TR199903310A2 (xx) 2000-10-23
SG90086A1 (en) 2002-07-23
BR9905974A (pt) 2000-09-12
PE20001368A1 (es) 2000-12-14
AU6534099A (en) 2000-07-06
EP1013639B1 (fr) 2003-10-01
RU2179969C2 (ru) 2002-02-27
IL133578A0 (en) 2001-04-30
CA2292921A1 (fr) 2000-06-23
KR20000048322A (ko) 2000-07-25
NO996366D0 (no) 1999-12-21
JP2000191523A (ja) 2000-07-11
HUP9904659A3 (en) 2000-12-28
DE69911726T2 (de) 2004-07-29
KR100378335B1 (ko) 2003-03-29
HU9904659D0 (en) 2000-02-28
TWI221834B (en) 2004-10-11
ATE251125T1 (de) 2003-10-15
PL337419A1 (en) 2000-07-03
DK1013639T3 (da) 2004-02-09
TR199903310A3 (tr) 2000-10-23
DE69911726D1 (de) 2003-11-06
AR029320A1 (es) 2003-06-25
HUP9904659A2 (hu) 2000-11-28
IL133578A (en) 2004-07-25
CA2292921C (fr) 2004-08-17
JP3415085B2 (ja) 2003-06-09
PT1013639E (pt) 2004-02-27
UY25876A1 (es) 2001-07-31
NO996366L (no) 2000-06-26
AU735640B2 (en) 2001-07-12
US6335459B1 (en) 2002-01-01
EP1013639A1 (fr) 2000-06-28
CN1266054A (zh) 2000-09-13
MA26713A1 (fr) 2004-12-20
NO316171B1 (no) 2003-12-22
ID25983A (id) 2000-11-16
CN1167670C (zh) 2004-09-22

Similar Documents

Publication Publication Date Title
HRP990394A2 (en) Aryl carboxylic acid and tetrazole derivatives
AU2018200368A1 (en) Compositions and methods of modulating 15-pgdh activity
JP2008515998A (ja) 化合物
JP4095899B2 (ja) 心血管疾患を治療するための薬剤としての側鎖ハロゲン化したアミノカルボン酸誘導体
ZA200101303B (en) Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process.
JP2007506755A (ja) 線溶系の障害および血栓症の治療用のｐａｉ−１阻害剤としての、（（（（１ｈ−インドール−３イル）メチリデン）アミノ）オキシ）酢酸誘導体およびその関連化合物
AU2004287586A1 (en) Phosphinic acids derivatives, beta-secretase inhibitors for the treatment of Alzheimer's disease
JP2000256259A (ja) メイラード反応阻害剤
JP2004529897A (ja) 心血管疾患を治療するための薬剤としてのハロゲン置換されたアミノジカルボン酸誘導体
US20030109570A1 (en) Benzothiophene derivatives and medicinal use thereof
JP2016539174A (ja) Ｓ１ｐ３アンタゴニスト
JPWO1994021599A1 (ja) 血小板凝集阻害作用を有する新規化合物
US20070167490A1 (en) Imino ether derivative compounds and drugs containing the compounds as the active ingredient
JP2588242B2 (ja) ジ‐ｔ‐ブチルフェニルアルキル及びベンジルエーテル
JPH0665209A (ja) イミダゾリル置換フエニルプロピオン酸および桂皮酸誘導体
JP2005537326A (ja) カテプシンシステインプロテアーゼ阻害薬
KR20080030052A (ko) 카텝신 ｋ 억제제
MXPA99011894A (en) Arilcarboxilic and tetra acid derivatives
JP5075124B2 (ja) フルクトース−１，６−ビスホスファターゼ阻害薬としてのイミダゾール誘導体およびそれらを含む医薬組成物
CZ457399A3 (cs) Modulátory receptoru prostaglandinu 12 (IP)
CA2099078A1 (fr) Derives du cyclohexane a substituant imidazolyle
HU191209B (en) Process for preparing 4h-furo/3,2-b/indole derivatives with antiallergic activity
JP2926168B2 (ja) 含硫黄化合物
JPH05262736A (ja) フェノキシ酢酸誘導体
CZ2001195A3 (cs) Cyklické sloučeniny vhodné k léčení dyslipidemie, atherosklerózy a diabetes, způsob jejich přípravy a farmaceutické prostředky, které je obsahují

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
OBST Application withdrawn